Product Information

TADALAFIL 20 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.1400 per EA under NDC 69097052603. Its NADAC has been published 385 times since Apr 10, 2019.

FDA first approved this application on Feb 5, 2019. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TADALAFIL 20 MG TABLET

Tadalafil
$0.1400per EA

Strength

20 mg/1

Manufacturer

Cipla USA Inc.

NDC

69097052603

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

TADALAFIL

Approval Type

Generic (ANDA)

FDA Application

ANDA210255

FDA Approved

2/5/2019

TE Code

AB2

On Market Since

2/5/2019

Pharmacological Classes

Phosphodiesterase 5 Inhibitor
Phosphodiesterase 5 Inhibitors

Price Statistics

The NADAC for TADALAFIL 20 MG TABLET has been published 385 times since Apr 10, 2019, and over the history we have for it it has declined 92.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1400 per EA
All-time high$1.9116 (May 15, 2019)
All-time low$0.1330 (Jul 22, 2026)
52-week high$0.2218
52-week low$0.1330
Median price$0.4498
Average price$0.5573
Largest weekly change+78.5% (Sep 18, 2019)
Weeks tracked385
Tracking sinceApr 10, 2019

Price History

1W

+5.3%

1M

+5.3%

3M

-5.3%

6M

-19.5%

1Y

-36.9%

3Y

-68.9%

5Y

-81.6%

All

-92.7%

Generic Alternatives

The matcher finds 17 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of TADALAFIL 20 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for TADALAFIL 20 MG TABLET, manufactured by Cipla USA Inc., is $0.1400 per EA (NDC 69097052603), effective Aug 19, 2026.

How has the price of TADALAFIL 20 MG TABLET changed over time?

Over the history we have for it, the NADAC for TADALAFIL 20 MG TABLET has declined 92.7%. It has been tracked across 385 weekly CMS publications since Apr 10, 2019.

What are the highest and lowest recorded NADAC prices for TADALAFIL 20 MG TABLET?

Since Apr 10, 2019, the NADAC for TADALAFIL 20 MG TABLET has ranged from a low of $0.1330 (Jul 22, 2026) to a high of $1.9116 (May 15, 2019), with a median of $0.4498 per EA.

Are there cheaper alternatives to TADALAFIL 20 MG TABLET?

17 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TADALAFIL 20 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures TADALAFIL 20 MG TABLET?

TADALAFIL 20 MG TABLET (NDC 69097052603) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.